<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>CLX (<z:chebi fb="0" ids="41423">celecoxib</z:chebi>), a selective COX-2 (cyclo-oxygenase-2) inhibitor, has numerous pleiotropic effects on the body that may be independent of its COX-2 inhibitory activity </plain></SENT>
<SENT sid="1" pm="."><plain>The <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> chemopreventive ability of CLX, particularly in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> (<z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e>), has been shown in epidemiological studies </plain></SENT>
<SENT sid="2" pm="."><plain>Here we have, for the first time, examined the biophysical effects of CLX on the cellular membranes of COX-2 expressing (HT29) and COX-2 non-expressing (SW620) cell lines using ATR-FTIR (attenuated total reflectance-Fourier transform IR) spectroscopy and SL-ESR (<z:chebi fb="0" ids="35210">spin label</z:chebi>-ESR) spectroscopy </plain></SENT>
<SENT sid="3" pm="."><plain>Our results show that CLX treatment decreased <z:chebi fb="23" ids="18059">lipid</z:chebi> fluidity in the <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cell lines irrespective of COX-2 expression status </plain></SENT>
<SENT sid="4" pm="."><plain>As metastatic cells have higher membrane fluidity, we examined the effect of CLX on the metastatic potential of these cells </plain></SENT>
<SENT sid="5" pm="."><plain>The CLX treatment efficiently decreased the proliferation, anchorage-independent growth, ability to close a scratch wound and migration and invasion of the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cell lines through Matrigel </plain></SENT>
<SENT sid="6" pm="."><plain>We propose that one of the ways by which CLX exerts its anti-tumorigenic effects is via alterations in cellular membrane fluidity which has a notable impact on the cells' metastatic potential </plain></SENT>
</text></document>